Bilibili Inc
NASDAQ:BILI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bilibili Inc
NASDAQ:BILI
|
CN |
|
S
|
Sumitomo Corp
XMUN:SUMA
|
JP |
|
M
|
MetLife Inc
XBER:MWZ
|
US |
|
Truist Financial Corp
NYSE:TFC
|
US |
|
Medpace Holdings Inc
NASDAQ:MEDP
|
US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
US |
|
C
|
Corcept Therapeutics Inc
F:HTD
|
US |
|
T
|
Talanx AG
XMUN:TLX
|
DE |
|
A
|
Asahi Kasei Corp
DUS:ASAA
|
JP |
|
M
|
MMG Ltd
F:OMS1
|
AU |
Wall St Price Targets
BILI Price Targets Summary
Bilibili Inc
According to Wall Street analysts, the average 1-year price target for BILI is 29.93 USD with a low forecast of 22.73 USD and a high forecast of 38.49 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BILI's stock price target?
Price Target
29.93
USD
According to Wall Street analysts, the average 1-year price target for BILI is 29.93 USD with a low forecast of 22.73 USD and a high forecast of 38.49 USD.
What is the Revenue forecast for Bilibili Inc?
Projected CAGR
9%
Over the last 9 years, the compound annual growth rate for Revenue has been 57%. The projected CAGR for the next 8 years is 9%.
What is the Gross Profit forecast for Bilibili Inc?
Projected CAGR
12%
The compound annual growth rate for Gross Profit over the next 8 years is 12%.
What is the Operating Income forecast for Bilibili Inc?
Projected CAGR
33%
The compound annual growth rate for Operating Income over the next 8 years is 33%.
What is the Pre-Tax Income forecast for Bilibili Inc?
Projected CAGR
58%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 58%.
What is the Net Income forecast for Bilibili Inc?
Projected CAGR
34%
The compound annual growth rate for Net Income over the next 8 years is 34%.
